NEW YORK, Aug. 27, 2020 /PRNewswire/ -- WeissLaw LLP is investigating possible breaches of fiduciary duty and other violations of law by the board of directors of Tortoise Acquisition Corp. ("SHLL" or the "Company") (NYSE: SHLL) in connection with the Company's proposed merger with privately-held powertrain solutions company Hyliion Inc. ("Hyliion"). Under the terms of the merger agreement, SHLL will acquire Hyliion through a reverse merger that will result in Hyliion becoming a publicly-listed company. Upon closing of the transaction, the combined company will be named Hyliion Holdings Corp. and will remain listed on the NYSE, trading under the new ticker symbol "HYLN." The new entity will have an implied pro forma market capitalization of approximately $1.5 billion.
If you own SHLL shares and wish to discuss this investigation or have any questions concerning this notice or your rights or interests, visit our website:
Or please contact: Joshua Rubin, Esq. WeissLaw LLP 1500 Broadway, 16th Floor New York, NY 10036 (212) 682-3025 (888) 593-4771 [email protected]
WeissLaw is investigating whether SHLL's board acted in the best interest of SHLL's public shareholders in agreeing to the proposed transaction, whether the board was fully informed as to the valuation of Hyliion, whether the deal's equity split is fair to SHLL shareholders, and whether all information regarding the valuation of the transaction is fully and fairly disclosed to SHLL public shareholders.
WeissLaw LLP has litigated hundreds of stockholder class and derivative actions for violations of corporate and fiduciary duties. We have recovered over a billion dollars for defrauded clients and obtained important corporate governance relief in many of these cases. If you have information or would like legal advice concerning possible corporate wrongdoing (including insider trading, waste of corporate assets, accounting fraud, or materially misleading information), consumer fraud (including false advertising, defective products, or other deceptive business practices), or anti-trust violations, please email us at [email protected]